{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:19:42Z","timestamp":1794899982122,"version":"4.9.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,8]]},"abstract":"<jats:p>\n                    This study investigates the correlation between circulating\n                    <jats:italic toggle=\"yes\">hsa-miR-21-5p<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">hsa-miR-133a-3p<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">hsa-miR-182-5p<\/jats:italic>\n                    , and bone density levels in human plasma. A total of 120 subjects with normal bone mass, osteopenia, and osteoporosis were recruited. RT-PCR was used to detect the relative expression levels of\n                    <jats:italic toggle=\"yes\">hsa-miR-21-5p<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">hsa-miR-133a-3p<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">hsa-miR-182-5p<\/jats:italic>\n                    in the plasma of the patients, and the correlation analysis was performed combined with physical examination data. Analyze the potential effects of\n                    <jats:italic toggle=\"yes\">hsa-miR-21-5p<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">hsa-miR-133a-3p<\/jats:italic>\n                    on bone metabolism using bioinformatics tools. Compared with the normal group, the expression of plasma\n                    <jats:italic toggle=\"yes\">hsa-miR-21-5p<\/jats:italic>\n                    was significantly down-regulated (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05) and\n                    <jats:italic toggle=\"yes\">hsa-miR-133a-3p<\/jats:italic>\n                    was significantly up-regulated in patients with abnormal bone mass (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). The expression of\n                    <jats:italic toggle=\"yes\">hsa-miR-182-5p<\/jats:italic>\n                    was not substantially different from that of the osteoporosis group. Further, one-factor analysis showed that\n                    <jats:italic toggle=\"yes\">hsa-miR-21-5p<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">hsa-miR-133a-3p<\/jats:italic>\n                    , age, and BMI were the influencing factors of primary osteoporosis (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05) and osteopenia was negatively correlated with the expression level of\n                    <jats:italic toggle=\"yes\">hsa-miR-21-5p<\/jats:italic>\n                    and BMI (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). We found through bioinformatics analysis that the Hub genes of\n                    <jats:italic toggle=\"yes\">hsa-miR-21-5p<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">hsa-miR-133a-3p<\/jats:italic>\n                    are associated with bone homeostasis imbalance.\n                    <jats:italic toggle=\"yes\">Hsa-miR-21-5p<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">hsa-miR-133a-3p<\/jats:italic>\n                    are significantly changed in the plasma of primary osteoporosis and osteopenia patients. The relative expression levels of\n                    <jats:italic toggle=\"yes\">miRNA21<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">miRNA133a<\/jats:italic>\n                    are correlated with bone mineral density levels. A large sample size study is required to validate its potential value as a clinical indicator.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043780","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T19:01:54Z","timestamp":1755198114000},"page":"e43780","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Potential associations between circulating levels of hsa-miR-21-5p, hsa-miR-133a-3p, and hsa-miR-182-5p with bone density levels"],"prefix":"10.1097","volume":"104","author":[{"given":"Yanfei","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Quzhou Maternal and Child Health Care Hospital, Quzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2160-5028","authenticated-orcid":false,"given":"Na","family":"Yan","sequence":"additional","affiliation":[{"name":"Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Dian Diagnostics Group Co., Ltd., Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Dian Diagnostics Group Co., Ltd., Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Quzhou Hospital of Zhejiang Medical & Health Group, Zhejiang Quhua Hospital, Quzhou, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261117","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41413-018-0012-0","article-title":"Omentin-1 prevents inflammation-induced osteoporosis by downregulating the pro-inflammatory cytokines.","volume":"6","author":"Rao","year":"2018","journal-title":"Bone Res"},{"key":"R2-20261117","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jbmr.3295","article-title":"Cherubism mice also deficient in c-fos exhibit inflammatory bone destruction executed by macrophages that express MMP14 despite the absence of TRAP+ osteoclasts.","volume":"33","author":"Kittaka","year":"2018","journal-title":"J Bone Miner Res"},{"key":"R3-20261117","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","article-title":"Disorders of bone remodeling.","volume":"6","author":"Feng","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"R4-20261117","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/0022034518764411","article-title":"Emerging role of extracellular vesicles in bone remodeling.","volume":"97","author":"Liu","year":"2018","journal-title":"J Dent Res"},{"key":"R5-20261117","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s12276-023-00956-8","article-title":"Circulating MiRNA-21-enriched extracellular vesicles promote bone remodeling in traumatic brain injury patients.","volume":"55","author":"Lin","year":"2023","journal-title":"Exp Mol Med"},{"key":"R6-20261117","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11914-013-0143-6","article-title":"MicroRNA functions in osteogenesis and dysfunctions in osteoporosis.","volume":"11","author":"van Wijnen","year":"2013","journal-title":"Curr Osteoporos Rep"},{"key":"R7-20261117","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA.","volume":"141","author":"Lu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R8-20261117","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis.","volume":"15","author":"Ha","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R9-20261117","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1042\/BSR20190667","article-title":"Differentially expressed circulating miRNAs in postmenopausal osteoporosis: a meta-analysis.","volume":"39","author":"Pala","year":"2019","journal-title":"Biosci Rep"},{"key":"R10-20261117","doi-asserted-by":"crossref","first-page":"151549","DOI":"10.1016\/j.acthis.2020.151549","article-title":"Astragalus saponin IV promotes osteogenic differentiation of bone marrow mesenchymal stem cells via miR-21\/NGF\/BMP2\/Runx2 pathway.","volume":"122","author":"Wu","year":"2020","journal-title":"Acta Histochem"},{"key":"R11-20261117","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1089\/dna.2021.0206","article-title":"MicroRNA-133a regulates the viability and differentiation fate of bone marrow mesenchymal stem cells via MAPK\/ERK signaling pathway by targeting FGFR1.","volume":"40","author":"Wang","year":"2021","journal-title":"DNA Cell Biol"},{"key":"R12-20261117","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13287-021-02278-w","article-title":"miR-133a silencing rescues glucocorticoid-induced bone loss by regulating the MAPK\/ERK signaling pathway.","volume":"12","author":"Wang","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"R13-20261117","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00223-015-0036-z","article-title":"Serum circulating microRNAs as biomarkers of osteoporotic fracture.","volume":"97","author":"Panach","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"R14-20261117","first-page":"505","article-title":"MicroRNA-182 inhibits osteogenic differentiation of bone marrow mesenchymal stem cells by targeting Smad1.","volume":"35","author":"Zheng","year":"2021","journal-title":"J Biol Regul Homeost Agents"},{"key":"R15-20261117","first-page":"937","article-title":"Expert consensus on the diagnosis and treatment of osteoporosis in primary medical institutions (2021).","volume":"27","year":"2021","journal-title":"Chin J Osteop"},{"key":"R16-20261117","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrm3254","article-title":"Building strong bones: molecular regulation of the osteoblast lineage.","volume":"13","author":"Long","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R17-20261117","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group.","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporos Int"},{"key":"R18-20261117","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3109\/1354750X.2014.935957","article-title":"Plasma miRNA levels correlate with sensitivity to bone mineral density in postmenopausal osteoporosis patients.","volume":"19","author":"Li","year":"2014","journal-title":"Biomarkers"},{"key":"R19-20261117","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/jbmr.2175","article-title":"Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures.","volume":"29","author":"Seeliger","year":"2014","journal-title":"J Bone Miner Res"},{"key":"R20-20261117","doi-asserted-by":"crossref","first-page":"722804","DOI":"10.3389\/fphar.2021.722804","article-title":"MicroRNA-21: an emerging player in bone diseases.","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"key":"R21-20261117","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.1038\/s41467-021-27273-w","article-title":"STAT3 is critical for skeletal development and bone homeostasis by regulating osteogenesis.","volume":"12","author":"Zhou","year":"2021","journal-title":"Nat Commun"},{"key":"R22-20261117","doi-asserted-by":"crossref","first-page":"e59079","DOI":"10.7554\/eLife.59079","article-title":"GAS5 protects against osteoporosis by targeting UPF1\/SMAD7 axis in osteoblast differentiation.","volume":"9","author":"Li","year":"2020","journal-title":"eLife"},{"key":"R23-20261117","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.1080\/21655979.2021.1977766","article-title":"MicroRNA-15a-5p plays a role in osteogenic MC3T3-E1 cells differentiation by targeting PDCD4 (programmed cell death 4) via Wnt\/\u03b2-catenin dependent signaling pathway.","volume":"12","author":"Wang","year":"2021","journal-title":"Bioengineered"},{"key":"R24-20261117","doi-asserted-by":"crossref","first-page":"573455","DOI":"10.3389\/fcell.2020.573455","article-title":"Yes-associated protein 1: role and treatment prospects in orthopedic degenerative diseases.","volume":"8","author":"Xie","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R25-20261117","doi-asserted-by":"crossref","first-page":"e8907","DOI":"10.7717\/peerj.8907","article-title":"Weighted gene correlation network analysis reveals novel biomarkers associated with mesenchymal stromal cell differentiation in early phase.","volume":"8","author":"Xiao","year":"2020","journal-title":"PeerJ"},{"key":"R26-20261117","doi-asserted-by":"crossref","first-page":"100617","DOI":"10.1016\/j.jbc.2021.100617","article-title":"miR-21-5p targets SKP2 to reduce osteoclastogenesis in a mouse model of osteoporosis.","volume":"296","author":"Huang","year":"2021","journal-title":"J Biol Chem"},{"key":"R27-20261117","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41419-020-2548-3","article-title":"QKI deficiency leads to osteoporosis by promoting RANKL-induced osteoclastogenesis and disrupting bone metabolism.","volume":"11","author":"Du","year":"2020","journal-title":"Cell Death Dis"},{"key":"R28-20261117","doi-asserted-by":"crossref","first-page":"111559","DOI":"10.1016\/j.mce.2022.111559","article-title":"ELAV-like RNA binding protein 1 regulates osteogenesis in diabetic osteoporosis: involvement of divalent metal transporter 1.","volume":"546","author":"Ren","year":"2022","journal-title":"Mol Cell Endocrinol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:01:00Z","timestamp":1794898860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":28,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043780","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"2024-08-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}